Resilience
Resilience specializes in biomanufacturing for biopharmaceuticals, offering comprehensive solutions from drug substance to drug product manufacturing, with facilities across North America.
Company Specialties in Biomanufacturing
Resilience specializes in biomanufacturing for biopharmaceuticals, including biologics, vaccines, nucleic acids, cell therapy, and gene therapy. The company focuses on providing high-quality, end-to-end drug substance and drug product manufacturing solutions to meet the diverse needs of its partners.
Comprehensive Process and Analytical Development Services
Resilience offers extensive process and analytical development (PAD) services. These services are crucial in advancing the biopharmaceutical manufacturing process, ensuring the highest standards in quality and efficiency from the early stages of research through to commercial production.
Advanced Biomanufacturing Technologies
Resilience utilizes advanced biomanufacturing technologies such as single-use suspension and adherent cell reactor technology, along with proprietary cell expression systems. These cutting-edge technologies enable the company to provide scalable and efficient manufacturing solutions that meet the evolving needs of the biopharmaceutical industry.
North American Manufacturing Facilities
Resilience operates state-of-the-art facilities across North America, equipped for both clinical and commercial manufacturing. These facilities are designed to support rapid, safe, and scalable production of biopharmaceutical treatments, ensuring the company's ability to meet growing demand.
Expert Regulatory Team
Resilience has a regulatory team with an average of over 20 years of experience. This team provides vital support across all stages of product development, from pre-clinical development through to licensure. Their expertise helps to navigate the complex regulatory landscape, ensuring compliance and facilitating smoother product approvals.